TELA BIO INC (TELA) Stock Earnings & Estimates
NASDAQ:TELA - US8723811084 - Common Stock
1.8 USD
-0.03 (-1.64%)
1.8171 USD
+0.02 (+0.95%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 41.42M 40.60% | 58.453M 41.12% | 69.3M 18.56% | 87.125M 25.72% | 106.32M 22.03% | 130.44M 22.69% | 163.36M 25.24% | |
| EBITDA YoY % growth | -37.83M -30.81% | -43.267M -14.37% | -40.683M 5.97% | -21.76M 46.51% | -3.143M 85.56% | 11.425M 463.55% | 26.684M 133.56% | |
| EBIT YoY % growth | -39.01M -32.46% | -44.075M -12.98% | -41.695M 5.40% | -28.816M 30.89% | -15.788M 45.21% | 6.191M 139.21% | 16.105M 160.14% | |
| Operating Margin | -94.18% | -75.40% | -60.17% | -33.07% | -14.85% | 4.75% | 9.86% | |
| EPS YoY % growth | -2.70 -17.90% | -2.07 23.33% | -1.39 32.85% | -0.80 42.25% | -0.50 37.87% | 0.02 104.09% | -0.35 -1,800.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 54.59% | -0.16 32.15% | -0.11 54.30% | -0.10 52.56% | -0.08 55.44% | -0.07 52.73% |
| Revenue Q2Q % growth | 22.224M 17.23% | 25.434M 44.11% | 23.494M 26.86% | 25.432M 25.92% | 27.438M 23.46% | 31.416M 23.52% |
| EBITDA Q2Q % growth | -6.073M 29.54% | -4.752M 35.27% | 220.32K 102.16% | -142.8K 98.33% | 32.64K 100.54% | 336.6K 107.08% |
| EBIT Q2Q % growth | -7.686M 17.93% | -5.98M 28.41% | -5.544M 47.06% | -5.012M 44.81% | -3.599M 53.18% | -2.682M 55.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.22 56.86% | -0.18 | -0.04 | -21.99% |
| Q1 2025 Q2Q % growth | -0.25 -8.70% | -0.20 | -0.05 | -25.31% |
| Q4 2024 Q2Q % growth | -0.23 56.60% | -0.23 | 0.00 | -1.21% |
| Q3 2024 Q2Q % growth | -0.42 6.67% | -0.41 | -0.01 | -1.82% |
| Q2 2024 Q2Q % growth | -0.51 -10.87% | -0.48 | -0.03 | -5.93% |
| Q1 2024 Q2Q % growth | -0.23 63.49% | -0.51 | 0.28 | 55.05% |
| Q4 2023 Q2Q % growth | -0.53 -1.92% | -0.44 | -0.09 | -19.51% |
| Q3 2023 Q2Q % growth | -0.45 29.69% | -0.50 | 0.05 | 10.29% |
| Q2 2023 Q2Q % growth | -0.46 41.77% | -0.54 | 0.08 | 15.39% |
| Q1 2023 Q2Q % growth | -0.63 16.00% | -0.57 | -0.06 | -10.45% |
| Q4 2022 Q2Q % growth | -0.52 11.86% | -0.56 | 0.04 | 6.63% |
| Q3 2022 Q2Q % growth | -0.64 -12.28% | -0.64 | 0.00 | -0.31% |
| Q2 2022 Q2Q % growth | -0.79 -38.60% | -0.63 | -0.16 | -25.33% |
| Q1 2022 Q2Q % growth | -0.75 -33.93% | -0.57 | -0.18 | -31.89% |
| Q4 2021 Q2Q % growth | -0.59 -9.26% | -0.56 | -0.03 | -5.65% |
| Q3 2021 Q2Q % growth | -0.57 -7.55% | -0.54 | -0.03 | -6.44% |
| Q2 2021 Q2Q % growth | -0.57 -7.55% | -0.53 | -0.04 | -7.47% |
| Q1 2021 Q2Q % growth | -0.56 11.11% | -0.49 | -0.07 | -13.79% |
| Q4 2020 Q2Q % growth | -0.54 55.74% | -0.50 | -0.04 | -8.49% |
| Q3 2020 Q2Q % growth | -0.53 -2,550.00% | -0.50 | -0.03 | -7.03% |
| Q2 2020 Q2Q % growth | -0.53 | -0.60 | 0.07 | 11.56% |
| Q1 2020 Q2Q % growth | -0.63 | -0.57 | -0.06 | -9.80% |
| Q4 2019 Q2Q % growth | -1.22 | -0.61 | -0.61 | -101.02% |
| Q3 2019 Q2Q % growth | -0.02 | -0.57 | 0.55 | 96.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 20.197M 25.52% | 21.094M | -897K | -4.25% |
| Q1 2025 Q2Q % growth | 18.52M 11.55% | 17.707M | 813K | 4.59% |
| Q4 2024 Q2Q % growth | 17.649M 3.83% | 23.63M | -5.981M | -25.31% |
| Q3 2024 Q2Q % growth | 18.957M 25.94% | 19.229M | -272K | -1.41% |
| Q2 2024 Q2Q % growth | 16.091M 11.02% | 18.829M | -2.738M | -14.54% |
| Q1 2024 Q2Q % growth | 16.603M 39.42% | 16.645M | -42K | -0.25% |
| Q4 2023 Q2Q % growth | 16.998M 46.28% | 16.72M | 278K | 1.66% |
| Q3 2023 Q2Q % growth | 15.052M 34.87% | 16.52M | -1.468M | -8.89% |
| Q2 2023 Q2Q % growth | 14.494M 39.23% | 14.69M | -196K | -1.33% |
| Q1 2023 Q2Q % growth | 11.909M 44.70% | 12.259M | -350K | -2.86% |
| Q4 2022 Q2Q % growth | 11.62M 38.83% | 13.453M | -1.833M | -13.63% |
| Q3 2022 Q2Q % growth | 11.16M 45.88% | 11.082M | 78K | 0.70% |
| Q2 2022 Q2Q % growth | 10.41M 37.70% | 10.324M | 86K | 0.83% |
| Q1 2022 Q2Q % growth | 8.23M 39.97% | 8.112M | 118K | 1.45% |
| Q4 2021 Q2Q % growth | 8.37M 47.62% | 8.137M | 233K | 2.86% |
| Q3 2021 Q2Q % growth | 7.65M 44.07% | 7.698M | -48K | -0.62% |
| Q2 2021 Q2Q % growth | 7.56M 115.38% | 6.438M | 1.122M | 17.43% |
| Q1 2021 Q2Q % growth | 5.88M 57.64% | 5.565M | 315K | 5.66% |
| Q4 2020 Q2Q % growth | 5.67M 16.67% | 5.918M | -248K | -4.19% |
| Q3 2020 Q2Q % growth | 5.31M 33.75% | 4.67M | 640K | 13.70% |
| Q2 2020 Q2Q % growth | 3.51M 6.36% | 1.971M | 1.539M | 78.08% |
| Q1 2020 Q2Q % growth | 3.73M 12.69% | 3.74M | -10K | -0.27% |
| Q4 2019 Q2Q % growth | 4.86M | 4.263M | 597K | 14.00% |
| Q3 2019 Q2Q % growth | 3.97M | 4.016M | -46K | -1.15% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -18.06% | -6.25% | -10.69% | -10.69% |
| Revenue | -1.97% | -8.17% | -0.75% | -0.52% |